Skip to main content

Resverlogix Corp(RVX-T)
TSX

Today's Change
Real-Time Last Update

Stocks in play: Resverlogix Corp.

Baystreet - Wed Jun 8, 2022

Today announced the publication of an article entitled “Breaking boundaries: Pan BETi disrupt 3D chromatin structure, BD2-selective BETi are strictly epigenetic transcriptional regulators” in the journal Biomedicine & Pharmacotherapy. The article uncovers a clear mechanism for the improved safety, and reduced off-target effects, seen with BD2-selective BET inhibitors in comparison with non-selective BET inhibitors. Resverlogix Corp. shares T.RVX are trading u0p $0.04 at $0.26.

Provided Content: Content provided by Baystreet. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe